Search - tctmd.com

Displaying 1 - 20 of 55

Sort: Relevancy | Date

Presentation TCT 2016

Global Hearts Action Plan for 2017

Presenter: Jack C. Lewin, Hugh J. Linnehan, Mpiko Ntsekhe

November 01, 2016

Presentation TCT 2016

Needs Assessment for Cath Lab Improvement and Support

Presenter: Jack C. Lewin, Hugh J. Linnehan, Graham A. Cassel

November 01, 2016

Presentation TCT 2016

PASCAR: Global Hearts Sub-Saharan Africa PCI Capacity Survey Results

Presenter: Jack C. Lewin, Hugh J. Linnehan, Habib Gamra

November 01, 2016

Presentation TCT 2016

Impact of Percutaneous Mitral Valve Repair and Replacement on RHD Patient Outcomes

Presenter: Habib Gamra, Ahmed Suliman, Hugh J. Linnehan

November 01, 2016

Presentation TCT 2016

Delivery System and Therapeutic Challenges with RHD in Africa

Presenter: Habib Gamra, Ahmed Suliman, Mohamed Ahmed Sobhy

November 01, 2016

Presentation TCT 2016

Update on Epidemiology, Prevention, Screening, and Control

Presenter: Habib Gamra, Ahmed Suliman, Bernard J. Gersh

November 01, 2016

Presentation TCT 2016

Delivery System and Therapeutic Challenges and Opportunities in Africa

Presenter: Graham A. Cassel, Harun A Otieno

November 01, 2016

Presentation TCT 2016

PCI of Non-Culprit Lesions in STEMI: Take-home Messages

Presenter: Graham A. Cassel

October 31, 2016

Presentation TCT 2016

PCI of Non-Culprit Lesions in STEMI: Flaws in the Previous Trials

Presenter: Graham A. Cassel, Nick Curzen

October 31, 2016

Presentation TCT 2016

PCI of Non-Culprit Lesion in STEMI: Literature Review

Presenter: Graham A. Cassel, Margaret B. McEntegart

October 31, 2016

Presentation TCT 2016

Case #2: STEMI in Patient With Left Main and Multivessel Disease

Presenter: Graham A. Cassel, Narek Zakaryan

October 31, 2016

Presentation TCT 2016

Case #1: STEMI in Patient With Moderate Bystander Disease

Presenter: Graham A. Cassel, Sergey A. Abugov

October 31, 2016

Presentation TCT 2016

Introduction: PCI of Non-Culprit Lesions in STEMI

Presenter: Graham A. Cassel

October 31, 2016

Presentation TCT 2016

Case Resolution: How Did We Treat this Patient?

Presenter: Nick Curzen, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

TAVR Restenosis: Review of the Literature

Presenter: Nick Curzen

October 31, 2016

Presentation TCT 2016

Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR

Presenter: Nick Curzen, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature

Presenter: Niall T. Mulvihill, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Presenter: Niall T. Mulvihill, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Presenter: Niall T. Mulvihill, Antoniette Neylon

October 31, 2016

Presentation TCT 2016

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Presenter: Niall T. Mulvihill

October 31, 2016

Advertisement

Global Hearts Action Plan for 2017

Needs Assessment for Cath Lab Improvement and Support

PASCAR: Global Hearts Sub-Saharan Africa PCI Capacity Survey Results

Impact of Percutaneous Mitral Valve Repair and Replacement on RHD Patient Outcomes

Delivery System and Therapeutic Challenges with RHD in Africa

Update on Epidemiology, Prevention, Screening, and Control

Delivery System and Therapeutic Challenges and Opportunities in Africa

PCI of Non-Culprit Lesions in STEMI: Take-home Messages

PCI of Non-Culprit Lesions in STEMI: Flaws in the Previous Trials

PCI of Non-Culprit Lesion in STEMI: Literature Review

Case #2: STEMI in Patient With Left Main and Multivessel Disease

Case #1: STEMI in Patient With Moderate Bystander Disease

Introduction: PCI of Non-Culprit Lesions in STEMI

Case Resolution: How Did We Treat this Patient?

TAVR Restenosis: Review of the Literature

Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR

TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content